ECC5004 is a GLP-1 receptor agonist that is taken orally rather than injected
Supplement Facts Ingredients: Water, L-Carnitine L-Tartrate, Acid (Citric acid), L-Ascorbic acid, Flavourings, Preservatives (Potassium sorbate, Sodium benzoate), Sweeteners (Acesulfame-K, Sucralose), D-pantothenate calcium, Pyridoxine hydrochloride, Colour (Tartrazine**), Chromium-picolinate
Eric Ravussin is both measuring the extent to which the medications affect muscle mass and exploring a way to prevent the drugs from decreasing patients metabolic rate
Abstract Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied
As of 2026, neither compound has FDA approval, limiting prescribing to research contexts or off-label use by physicians specializing in obesity medicine or endocrinology